You are here: Home » Specials » SI » Others
Business Standard

Laurus Labs sets IPO price band at Rs 426-428 per share

The firm proposes to use the net proceeds from the fresh issue towards pre-payment of term loans

Press Trust of India  |  New Delhi 

Domestic i-banks gain edge in IPOs

Pharma company will launch its initial public offering (IPO) next week and it has fixed the price band at Rs 426-428 per equity share. The IPO 

is scheduled to open on December 6 and close on December 8, the company said.

The offer consists of fresh issue of equity shares aggregating up to Rs 300 crore and an offer for sale of 24,107,440 equity shares by the selling 

shareholders namely Aptuit (Asia) Private, Bluewater Investment, FIL Capital Management (Mauritius) and Fidelity India Principals (acting through its 

trustee FIL Capital Advisors). The Hyderabad-based company will not receive any proceeds from the offer for sale and all proceeds from this will go to the 

selling shareholders, the statement said.

The firm proposes to use the net proceeds from the fresh issue towards pre-payment of term loans and general corporate purposes.

Kotak Mahindra Capital Company Limited, Citigroup Global Markets India Private Limited, Jefferies India Private Limited and SBI Capital Markets Ltd are the 

Book Running Lead Managers to the offer.

The registrar to the offer is Karvy Computershare Private Limited.

The equity shares of the company are proposed to be listed on BSE and NSE.

RECOMMENDED FOR YOU

Laurus Labs sets IPO price band at Rs 426-428 per share

The firm proposes to use the net proceeds from the fresh issue towards pre-payment of term loans

The firm proposes to use the net proceeds from the fresh issue towards pre-payment of term loans
Pharma company will launch its initial public offering (IPO) next week and it has fixed the price band at Rs 426-428 per equity share. The IPO 

is scheduled to open on December 6 and close on December 8, the company said.

The offer consists of fresh issue of equity shares aggregating up to Rs 300 crore and an offer for sale of 24,107,440 equity shares by the selling 

shareholders namely Aptuit (Asia) Private, Bluewater Investment, FIL Capital Management (Mauritius) and Fidelity India Principals (acting through its 

trustee FIL Capital Advisors). The Hyderabad-based company will not receive any proceeds from the offer for sale and all proceeds from this will go to the 

selling shareholders, the statement said.

The firm proposes to use the net proceeds from the fresh issue towards pre-payment of term loans and general corporate purposes.

Kotak Mahindra Capital Company Limited, Citigroup Global Markets India Private Limited, Jefferies India Private Limited and SBI Capital Markets Ltd are the 

Book Running Lead Managers to the offer.

The registrar to the offer is Karvy Computershare Private Limited.

The equity shares of the company are proposed to be listed on BSE and NSE.

image
Business Standard
177 22

Laurus Labs sets IPO price band at Rs 426-428 per share

The firm proposes to use the net proceeds from the fresh issue towards pre-payment of term loans

Pharma company will launch its initial public offering (IPO) next week and it has fixed the price band at Rs 426-428 per equity share. The IPO 

is scheduled to open on December 6 and close on December 8, the company said.

The offer consists of fresh issue of equity shares aggregating up to Rs 300 crore and an offer for sale of 24,107,440 equity shares by the selling 

shareholders namely Aptuit (Asia) Private, Bluewater Investment, FIL Capital Management (Mauritius) and Fidelity India Principals (acting through its 

trustee FIL Capital Advisors). The Hyderabad-based company will not receive any proceeds from the offer for sale and all proceeds from this will go to the 

selling shareholders, the statement said.

The firm proposes to use the net proceeds from the fresh issue towards pre-payment of term loans and general corporate purposes.

Kotak Mahindra Capital Company Limited, Citigroup Global Markets India Private Limited, Jefferies India Private Limited and SBI Capital Markets Ltd are the 

Book Running Lead Managers to the offer.

The registrar to the offer is Karvy Computershare Private Limited.

The equity shares of the company are proposed to be listed on BSE and NSE.

image
Business Standard
177 22